ANAESTHESIA 润色咨询

ANAESTHESIA

出版年份：1946 年文章数：1308 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：28.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2022-05-04 lwyjerry

    好像要突破11分了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    3个月

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2018-10-15 ms7296194897309127

    绝对是麻醉学里top期刊之一了，文章质量都相当高！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2018-03-30 1def8077m26(暂无匿称)

    投稿命中率:25.0
    经验分享：请问现在投稿周期怎样

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1216776, encodeId=c5e41216e7664, content=好像要突破11分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f1996599, createdName=lwyjerry, createdTime=Wed May 04 14:12:29 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578660, encodeId=dd6c5e8660f0, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847685, encodeId=f60a84e68585, content=绝对是麻醉学里top期刊之一了，文章质量都相当高！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Mon Oct 15 11:48:16 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554329, encodeId=a5f9554329e9, content=投稿命中率:25.0<br>经验分享：请问现在投稿周期怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/16/7ead9fbf759bf47ba8d72a22ccd6a850.jpg, createdBy=52871735106, createdName=1def8077m26(暂无匿称), createdTime=Fri Mar 30 10:24:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492271, encodeId=eeca4922e1d4, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475218, encodeId=8f3a4e521858, content=审稿速度:6.0 | 投稿命中率:20.0<br>经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d837909, createdName=rachel03, createdTime=Tue May 10 16:47:00 CST 2011, time=2011-05-10, status=1, ipAttribution=)]
    2011-05-10 rachel03

    审稿速度:6.0 | 投稿命中率:20.0
    经验分享：比较难投，第一次投了退稿，第二次补了数据再投，过了4、5个月回来要修改，修改了倒是很快就接受，但是实验数据不是很难做的，比较考虑疫苗的活性。

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分